Detalhe da pesquisa
1.
Reinvestigation of unidentified causative variants in FXI-deficient patients: Focus on gene segment deletions.
Haemophilia
; 29(1): 248-255, 2023 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-36195107
2.
The challenge of genetically unresolved haemophilia A patients: Interest of the combination of whole F8 gene sequencing and functional assays.
Haemophilia
; 26(6): 1056-1063, 2020 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-33094873
3.
Von Willebrand Factor Multimers during Transcatheter Aortic-Valve Replacement.
N Engl J Med
; 375(4): 335-44, 2016 Jul 28.
Artigo
Inglês
| MEDLINE | ID: mdl-27464202
4.
Relevance of platelet desialylation and thrombocytopenia in type 2B von Willebrand disease: preclinical and clinical evidence.
Haematologica
; 104(12): 2493-2500, 2019 12.
Artigo
Inglês
| MEDLINE | ID: mdl-30819911
5.
Management of bleeding and invasive procedures in haemophilia A patients with inhibitor treated with emicizumab (Hemlibra® ): Proposals from the French network on inherited bleeding disorders (MHEMO), the French Reference Centre on Haemophilia, in collaboration with the French Working Group on Perioperative Haemostasis (GIHP).
Haemophilia
; 25(5): 731-737, 2019 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-31294904
6.
Recombinant factor VIII products and inhibitor development in previously untreated patients with severe haemophilia A: Combined analysis of three studies.
Haemophilia
; 25(3): 398-407, 2019 May.
Artigo
Inglês
| MEDLINE | ID: mdl-31066174
7.
FranceCoag: a 22-year prospective follow-up of the national French cohort of patients with inherited bleeding disorders.
Eur J Epidemiol
; 34(5): 521-532, 2019 May.
Artigo
Inglês
| MEDLINE | ID: mdl-30515664
8.
Analyses of the FranceCoag cohort support differences in immunogenicity among one plasma-derived and two recombinant factor VIII brands in boys with severe hemophilia A.
Haematologica
; 103(1): 179-189, 2018 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29025913
9.
Von Willebrand factor as a biological sensor of blood flow to monitor percutaneous aortic valve interventions.
Circ Res
; 116(7): 1193-201, 2015 Mar 27.
Artigo
Inglês
| MEDLINE | ID: mdl-25670067
10.
Recombinant factor VIII products and inhibitor development in previously untreated boys with severe hemophilia A.
Blood
; 124(23): 3398-408, 2014 Nov 27.
Artigo
Inglês
| MEDLINE | ID: mdl-25253771
11.
The homozygous variant p.Gln1311* in exon 28 of VWF is associated with the development of alloantibodies in 3 unrelated patients with type 3 VWD.
Haemophilia
; 27(4): e491-e494, 2021 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-33403757
12.
Expanding the Mutation Spectrum Affecting αIIbß3 Integrin in Glanzmann Thrombasthenia: Screening of the ITGA2B and ITGB3 Genes in a Large International Cohort.
Hum Mutat
; 36(5): 548-61, 2015 May.
Artigo
Inglês
| MEDLINE | ID: mdl-25728920
13.
Mutations in the A3 domain of von Willebrand factor inducing combined qualitative and quantitative defects in the protein.
Blood
; 121(11): 2135-43, 2013 Mar 14.
Artigo
Inglês
| MEDLINE | ID: mdl-23335371
14.
VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease.
Blood
; 121(12): 2336-9, 2013 Mar 21.
Artigo
Inglês
| MEDLINE | ID: mdl-23349392
15.
EQOFIX: a combined economic and quality-of-life study of hemophilia B treatments in France.
Transfusion
; 55(7): 1787-97, 2015 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-25652955
16.
Clinical and prognostic implications of low or high level of von Willebrand factor in patients with Waldenstrom macroglobulinemia.
Blood
; 120(16): 3214-21, 2012 Oct 18.
Artigo
Inglês
| MEDLINE | ID: mdl-22896002
17.
Colon cancer surgery in von Willebrand disease type 3 setting triggering vascular abnormalities on bowel anastomosis.
Res Pract Thromb Haemost
; 7(5): 100277, 2023 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-37601018
18.
Efficacy and safety of von Willebrand factor concentrate almost devoid of factor VIII (Wilfactin®) in paediatric patients under 6 years of age with severe von Willebrand disease.
Blood Transfus
; 21(1): 83-92, 2023 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35543677
19.
von Willebrand factor neutralizing and non-neutralizing alloantibodies in 213 subjects with type 3 von Willebrand disease enrolled in 3WINTERS-IPS.
J Thromb Haemost
; 21(4): 787-799, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36792472
20.
Response: Confounding by indication is unlikely to explain the higher inhibitor incidence in boys treated with a recombinant FVIII product.
Blood
; 125(24): 3817-9, 2015 Jun 11.
Artigo
Inglês
| MEDLINE | ID: mdl-26069335